COFCO Biotechnology Co., Ltd. (000930.SZ)
CNY 5.81
(-0.68%)
CNY 5.81
(-0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 20.28 Billion | 19.91 Billion | 23.46 Billion | 19.9 Billion | 19.47 Billion | 17.7 Billion |
| Cost of Revenue | 19.79 Billion | 17.66 Billion | 20.84 Billion | 17.82 Billion | 16.73 Billion | 14.8 Billion |
| Gross Profit | 492.28 Million | 2.25 Billion | 2.62 Billion | 2.08 Billion | 2.73 Billion | 2.9 Billion |
| Operating Expenses | 1.69 Billion | 553.1 Million | 752.61 Million | 859.99 Million | 1.13 Billion | 1.51 Billion |
| Selling, General and Administrative Expenses | 707.68 Million | 345.21 Million | 374.3 Million | 346.24 Million | 1.3 Billion | 1.35 Billion |
| Research and Development Expenses | 165.61 Million | 132.86 Million | 119.27 Million | 113.67 Million | 87.15 Million | 96.26 Million |
| Other Expenses | 198.9 Million | 75.02 Million | 259.02 Million | 400.07 Million | -258.23 Million | 3.91 Million |
| Cost and Expenses | 20.95 Billion | 18.21 Billion | 21.59 Billion | 18.68 Billion | 17.86 Billion | 16.31 Billion |
| Operating Income | -455.42 Million | 1.35 Billion | 1.92 Billion | 1.19 Billion | 1.65 Billion | 614.22 Million |
| Interest Expense | 112.78 Million | 87.12 Million | 157.78 Million | 94.32 Million | 162.12 Million | 163.12 Million |
| Income Tax Expense | 73.75 Million | 298.94 Million | 250.08 Million | 173.75 Million | 107.46 Million | 100.43 Million |
| Earnings before Tax | -539.67 Million | 1.35 Billion | 1.38 Billion | 801.94 Million | 666.33 Million | 617.8 Million |
| Net Income | -601.62 Million | 1.05 Billion | 1.12 Billion | 593.11 Million | 592.82 Million | 483.04 Million |
| Earnings Per Share Basic | -0.33 | 0.57 | 0.61 | 0.32 | 0.32 | 0.26 |
| Earnings Per Share Diluted | -0.33 | 0.57 | 0.61 | 0.32 | 0.32 | 0.26 |
| Weighted Average Shares Outstanding | 1.84 Billion | 1.86 Billion | 1.86 Billion | 1.84 Billion | 1.84 Billion | 1.84 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.84 Billion | 1.86 Billion | 1.86 Billion | 1.85 Billion | 1.84 Billion | 1.85 Billion |
| Gross Margin | 0.02 | 0.11 | 0.11 | 0.10 | 0.14 | 0.16 |
| EBIT Margin | 0.00 | 0.11 | 0.10 | 0.08 | 0.11 | 0.11 |
| Profit Margin | -0.03 | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 |
| EBITDA | 62.08 Million | 1.9 Billion | 1.98 Billion | 1.33 Billion | 1.25 Billion | 1.39 Billion |
| Earnings Before Tax Margin | -0.02 | 0.07 | 0.08 | 0.06 | 0.09 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.21 Billion | 5.15 Billion | 4.71 Billion | 5.63 Billion | 20.28 Billion | 5.41 Billion |
| Cost of Revenue | 4.84 Billion | 4.78 Billion | 4.38 Billion | 5.4 Billion | 19.34 Billion | 5.04 Billion |
| Gross Profit | 365.13 Million | 369.86 Million | 323.44 Million | 232.94 Million | 948.4 Million | 369.58 Million |
| Operating Expenses | 234.31 Million | 309.8 Million | 273.74 Million | 523.39 Million | 1.4 Billion | 246.47 Million |
| Selling, General and Administrative Expenses | 523.03 Million | 193.7 Million | 157.49 Million | 227.21 Million | - | 401.24 Million |
| Research and Development Expenses | 23.83 Million | 51.47 Million | 30.61 Million | 51.34 Million | - | 39.51 Million |
| Other Expenses | -312.54 Million | -64.62 Million | -85.62 Million | -244.82 Million | -534.2 Million | 4.78 Million |
| Cost and Expenses | 5.08 Billion | 5.09 Billion | 4.66 Billion | 5.92 Billion | 20.74 Billion | 5.28 Billion |
| Operating Income | -24.57 Million | 60.06 Million | 49.7 Million | -290.44 Million | -455.42 Million | 43.71 Million |
| Interest Expense | 29.21 Million | 30.17 Million | 23.39 Million | 22.28 Million | 112.78 Million | 29.34 Million |
| Income Tax Expense | 36.51 Million | 37.7 Million | 26.35 Million | -23.35 Million | 73.75 Million | 40.81 Million |
| Earnings before Tax | -8.64 Million | 79.46 Million | 50.95 Million | -294.25 Million | -539.67 Million | 48.5 Million |
| Net Income | -51.87 Million | 36.64 Million | 24.84 Million | -268.76 Million | -601.62 Million | 2.37 Million |
| Earnings Per Share Basic | -0.03 | 0.02 | 0.01 | -0.14 | - | 0.00 |
| Earnings Per Share Diluted | -0.03 | 0.02 | 0.01 | -0.14 | - | 0.00 |
| Weighted Average Shares Outstanding | 1.85 Billion | 1.86 Billion | 1.85 Billion | 1.85 Billion | 1.84 Billion | 1.86 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.85 Billion | 1.86 Billion | 1.85 Billion | 1.85 Billion | 1.84 Billion | 1.86 Billion |
| Gross Margin | 0.07 | 0.07 | 0.07 | 0.04 | 0.05 | 0.07 |
| EBIT Margin | 0.00 | 0.04 | 0.03 | -0.03 | - | 0.03 |
| Profit Margin | -0.01 | 0.01 | 0.01 | -0.05 | -0.03 | 0.00 |
| EBITDA | 20.56 Million | 190.89 Million | 156.91 Million | -161.14 Million | - | 147.41 Million |
| Earnings Before Tax Margin | -0.00 | 0.01 | 0.01 | -0.05 | -0.02 | 0.01 |
HEN
ESLA
CNNC
CMPO
SDZNY
DQJCY